NasdaqCM - Nasdaq Real Time Price USD

Aclarion, Inc. (ACON)

Compare
0.0423 -0.0027 (-6.00%)
At close: January 17 at 4:00:01 p.m. EST
0.0424 +0.00 (+0.24%)
After hours: January 17 at 7:59:57 p.m. EST
Loading Chart for ACON
DELL
  • Previous Close 0.0450
  • Open 0.0467
  • Bid --
  • Ask --
  • Day's Range 0.0410 - 0.0484
  • 52 Week Range 0.0330 - 3.8500
  • Volume 96,456,984
  • Avg. Volume 15,673,401
  • Market Cap (intraday) 977,929
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) --
  • EPS (TTM) -2.4000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.30

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

www.aclarion.com

4

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Health Information Services

Industry

Recent News: ACON

View More

Performance Overview: ACON

Trailing total returns as of 2025-01-17, which may include dividends or other distributions. Benchmark is

.

YTD Return

ACON
70.83%
S&P 500
1.52%

1-Year Return

ACON
98.66%
S&P 500
25.82%

3-Year Return

ACON
99.91%
S&P 500
28.61%

5-Year Return

ACON
99.91%
S&P 500
80.80%

Compare To: ACON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACON

View More

Valuation Measures

Annual
As of 2025-01-17
  • Market Cap

    977.93k

  • Enterprise Value

    582.33k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.10

  • Price/Book (mrq)

    0.39

  • Enterprise Value/Revenue

    11.81

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -115.33%

  • Return on Equity (ttm)

    -714.18%

  • Revenue (ttm)

    53.95k

  • Net Income Avi to Common (ttm)

    -5.9M

  • Diluted EPS (ttm)

    -2.4000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.22M

  • Total Debt/Equity (mrq)

    47.32%

  • Levered Free Cash Flow (ttm)

    -3.94M

Research Analysis: ACON

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 14.41k
Earnings -1.38M
Q3'23
Q1'24
Q2'24
Q3'24
-2M
-2M
-1M
-500K
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1.30
1.30 Average
0.0423 Current
1.30 High
 

Company Insights: ACON

People Also Watch